{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:05:00Z","timestamp":1794024300283,"version":"4.8.0"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of the review<\/jats:title>\n            <jats:p>Pulmonary fibrosis (PF) is characterized by relentless scarring of the lungs, declining lung function, and increasing symptom burden. In PF, dyspnea and cough are the most common symptoms, severely impacting quality of life. This review highlights recent advances in understanding their mechanisms and explores evolving strategies for management of these symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Advances in non-pharmacologic approaches, including hand-held fans, dyspnea services and pulmonary rehabilitation are playing a vital role in dyspnea management. Opioids, while effective in reducing exertional dyspnea in controlled settings, show limited benefit for daily life breathlessness and are associated with significant adverse events, highlighting the need for cautious, individualized use. For refractory cough, promising studies are investigating the role of opioids and neuromodulatory therapies. Non-pharmacologic approaches, including speech therapy, and behavioral interventions, provide complementary approaches. A multidisciplinary approach and individualized care plans to address the multifactorial nature of dyspnea and cough are key.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Effective management of dyspnea and cough can importantly improve patients' quality of life. Further research is required to refine treatment protocols, optimize palliative care interventions, and identify and test novel therapeutics. Translation of these findings into clinical practice requires a focus on evidence-based, patient-centered care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000753","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T06:08:10Z","timestamp":1743228490000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Cough and dyspnea management in pulmonary fibrosis"],"prefix":"10.1097","volume":"19","author":[{"given":"Allard","family":"van Veelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies S.","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-017-0560-x","article-title":"Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey","volume":"18","author":"Cosgrove","year":"2018","journal-title":"BMC Pulm Med"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/09031936.00217614","article-title":"Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry","volume":"46","author":"Behr","year":"2015","journal-title":"Eur Respir J"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1164\/rccm.202311-2169LE","article-title":"Cough severity visual analog scale assesses cough burden and predicts survival in idiopathic pulmonary fibrosis","volume":"209","author":"Wu","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"2202014","DOI":"10.1183\/13993003.02014-2022","article-title":"European respiratory society clinical practice guideline: palliative care for people with COPD or interstitial lung disease","volume":"62","author":"Janssen","year":"2023","journal-title":"Eur Respir J"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/resp.14493","article-title":"Palliative care for interstitial lung disease: a nationwide survey of pulmonary specialists","volume":"28","author":"Fujisawa","year":"2023","journal-title":"Respirology"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4081\/mrm.2023.896","article-title":"Palliative care and end of life management in patients with idiopathic pulmonary fibrosis","volume":"18","author":"Micco","year":"2023","journal-title":"Multidiscip Respir Med"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1513\/AnnalsATS.202305-483ED","article-title":"Assessing the burden and prognostic value of cough in idiopathic pulmonary fibrosis","volume":"20","author":"Johnston","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.202302-174OC","article-title":"The burden and impact of cough in patients with idiopathic pulmonary fibrosis: an analysis of the prospective observational PROFILE study","volume":"20","author":"Saunders","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1183\/16000617.0090-2015","article-title":"Cough in idiopathic pulmonary fibrosis","volume":"25","author":"van Manen","year":"2016","journal-title":"Eur Respir Rev"},{"key":"R11-20250514","doi-asserted-by":"crossref","first-page":"00310","DOI":"10.1183\/23120541.00310-2024","article-title":"Objective measurement of cough in pulmonary fibrosis: a cohort study \u2013 ImpaCT","volume":"10","author":"Kebbe","year":"2024","journal-title":"ERJ Open Res"},{"key":"R12-20250514","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200304-597OC","article-title":"A study of the cough reflex in idiopathic pulmonary fibrosis","volume":"168","author":"Hope-Gill","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20250514","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12931-024-02897-w","article-title":"The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis","volume":"25","author":"Green","year":"2024","journal-title":"Respir Res"},{"key":"R14-20250514","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chest.2022.03.025","article-title":"Cough-specific quality of life predicts disease progression among patients with interstitial lung disease: data from the pulmonary fibrosis foundation patient registry","volume":"162","author":"Lee","year":"2022","journal-title":"Chest"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"38","DOI":"10.33590\/emjrespir\/10312904","article-title":"Nerves, cough, and idiopathic pulmonary fibrosis","volume":"3","author":"Harrison","year":"2015","journal-title":"EMJ Respir"},{"key":"R16-20250514","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S2213-2600(17)30310-7","article-title":"A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial","volume":"5","author":"Birring","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1440-1843.2011.01996.x","article-title":"Cough predicts prognosis in idiopathic pulmonary fibrosis","volume":"16","author":"Ryerson","year":"2011","journal-title":"Respirology"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/thoraxjnl-2018-212102","article-title":"Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis","volume":"74","author":"Dutta","year":"2019","journal-title":"Thorax"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1183\/13993003.00488-2016","article-title":"Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre","volume":"48","author":"Raghu","year":"2016","journal-title":"Eur Respir J"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-2600(23)00432-0","article-title":"Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial","volume":"12","author":"Wu","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R21-20250514","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-9974-10-4","article-title":"Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study","volume":"10","author":"Kilduff","year":"2014","journal-title":"Cough"},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1513\/AnnalsATS.201807-481OC","article-title":"Idiopathic pulmonary fibrosis and lung cancer. a systematic review and meta-analysis","volume":"16","author":"Brown","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R23-20250514","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rmed.2016.12.016","article-title":"Etiology and treatment of cough in idiopathic pulmonary fibrosis","volume":"123","author":"Vigeland","year":"2017","journal-title":"Respir Med"},{"key":"R24-20250514","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.201508-1638OC","article-title":"Stretch-induced activation of transforming growth factor-beta1 in pulmonary fibrosis","volume":"194","author":"Froese","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20250514","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.202311-2101OC","article-title":"Epidemiology and prognostic significance of cough in fibrotic interstitial lung disease","volume":"210","author":"Khor","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-20250514","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaip.2024.10.046","article-title":"Cough reflex hypersensitivity as a key treatable trait","volume":"13","author":"Song","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R27-20250514","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s41030-021-00162-9","article-title":"Treatment of persistent cough in subjects with Idiopathic Pulmonary Fibrosis (IPF) with gefapixant, a P2X3 Antagonist, in a randomized, placebo-controlled clinical trial","volume":"7","author":"Martinez","year":"2021","journal-title":"Pulm Ther"},{"key":"R28-20250514","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00408-024-00723-0","article-title":"Patient Perception of Cough in Interstitial Lung Disease; Impact of Cough Hypersensitivity","volume":"202","author":"Hirons","year":"2024","journal-title":"Lung"},{"key":"R29-20250514","doi-asserted-by":"crossref","first-page":"EVIDe2300126","DOI":"10.1056\/EVIDe2300126","article-title":"Managing chronic cough associated with idiopathic pulmonary fibrosis \u2013 will nalbuphine fill an unmet need?","volume":"2","author":"Irwin","year":"2023","journal-title":"NEJM Evid"},{"key":"R30-20250514","doi-asserted-by":"crossref","first-page":"EVIDoa2300083","DOI":"10.1056\/EVIDoa2300083","article-title":"Nalbuphine tablets for cough in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Maher","year":"2023","journal-title":"NEJM Evid"},{"key":"R31-20250514","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13063-022-06068-4","article-title":"PAciFy Cough \u2013 a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary fibrosis cough","volume":"23","author":"Wu","year":"2022","journal-title":"Trials"},{"key":"R32-20250514","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1513\/AnnalsATS.202103-266OC","article-title":"Azithromycin for the treatment of chronic cough in idiopathic pulmonary fibrosis: a randomized controlled crossover trial","volume":"18","author":"Guler","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"R33-20250514","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.202106-1485OC","article-title":"Phase 2B study of inhaled RVT-1601 for chronic cough in idiopathic pulmonary fibrosis: a multicenter, randomized, placebo-controlled study (SCENIC TRIAL)","volume":"205","author":"Martinez","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R34-20250514","doi-asserted-by":"crossref","first-page":"2300752","DOI":"10.1183\/13993003.00752-2023","article-title":"Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis","volume":"63","author":"Wijsenbeek","year":"2024","journal-title":"Eur Respir J"},{"key":"R35-20250514","doi-asserted-by":"crossref","first-page":"1701157","DOI":"10.1183\/13993003.01157-2017","article-title":"Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis","volume":"50","author":"van Manen","year":"2017","journal-title":"Eur Respir J"},{"key":"R36-20250514","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-20250514","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R38-20250514","doi-asserted-by":"crossref","first-page":"e15579","DOI":"10.1016\/j.heliyon.2023.e15579","article-title":"Gabapentin for chronic refractory cough: a system review and meta-analysis","volume":"9","author":"Xie","year":"2023","journal-title":"Heliyon"},{"key":"R39-20250514","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.chest.2019.08.001","article-title":"The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough: results from a phase 2 pilot study (VOLCANO-1)","volume":"157","author":"Smith","year":"2020","journal-title":"Chest"},{"key":"R40-20250514","doi-asserted-by":"crossref","first-page":"17534666241305952","DOI":"10.1177\/17534666241305952","article-title":"Efficacy of behavioral cough suppression therapy for refractory chronic cough or unexplained chronic cough: a meta-analysis of randomized controlled trials","volume":"18","author":"Yi","year":"2024","journal-title":"Ther Adv Respir Dis"},{"key":"R41-20250514","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thoraxjnl-2016-208843","article-title":"Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial","volume":"72","author":"Chamberlain Mitchell","year":"2017","journal-title":"Thorax"},{"key":"R42-20250514","doi-asserted-by":"crossref","first-page":"2400335","DOI":"10.1183\/13993003.00335-2024","article-title":"European respiratory society clinical practice guideline on symptom management for adults with serious respiratory illness","volume":"63","author":"Holland","year":"2024","journal-title":"Eur Respir J"},{"key":"R43-20250514","first-page":"CD013067","article-title":"Speech and language therapy for management of chronic cough","volume":"7","author":"Slinger","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R44-20250514","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thoraxjnl-2017-210177","article-title":"Timing of onset of symptoms in people with idiopathic pulmonary fibrosis","volume":"73","author":"Hewson","year":"2018","journal-title":"Thorax"},{"key":"R45-20250514","doi-asserted-by":"crossref","first-page":"170062","DOI":"10.1183\/16000617.0062-2017","article-title":"Physiology of the lung in idiopathic pulmonary fibrosis","volume":"27","author":"Plantier","year":"2018","journal-title":"Eur Respir Rev"},{"key":"R46-20250514","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jpainsymman.2019.12.364","article-title":"Idiopathic pulmonary fibrosis: a review of disease, pharmacological, and nonpharmacological strategies with a focus on symptoms, function, and health-related quality of life","volume":"59","author":"Rozenberg","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"R47-20250514","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s10020-020-00223-w","article-title":"Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis","volume":"26","author":"Yang","year":"2020","journal-title":"Mol Med"},{"key":"R48-20250514","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00418-018-1747-9","article-title":"The micromechanics of lung alveoli: structure and function of surfactant and tissue components","volume":"150","author":"Knudsen","year":"2018","journal-title":"Histochem Cell Biol"},{"key":"R49-20250514","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S2213-2600(17)30383-1","article-title":"Palliative care in interstitial lung disease: living well","volume":"5","author":"Kreuter","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R50-20250514","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/thoraxjnl-2016-208638","article-title":"The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial","volume":"72","author":"Dowman","year":"2017","journal-title":"Thorax"},{"key":"R51-20250514","doi-asserted-by":"crossref","first-page":"1205924","DOI":"10.3389\/fphys.2023.1205924","article-title":"Chronic pulmonary fibrosis alters the functioning of the respiratory neural network","volume":"14","author":"Yegen","year":"2023","journal-title":"Front Physiol"},{"key":"R52-20250514","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00441-016-2559-7","article-title":"The nervous system of airways and its remodeling in inflammatory lung diseases","volume":"367","author":"Audrit","year":"2017","journal-title":"Cell Tissue Res"},{"key":"R53-20250514","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/NJH.0000000000000687","article-title":"Managing dyspnea in individuals with idiopathic pulmonary fibrosis","volume":"22","author":"Fenwick","year":"2020","journal-title":"J Hosp Palliat Nurs"},{"key":"R54-20250514","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s41030-019-00108-2","article-title":"The role of palliative care in reducing symptoms and improving quality of life for patients with idiopathic pulmonary fibrosis: a review","volume":"6","author":"Zou","year":"2020","journal-title":"Pulm Ther"},{"key":"R55-20250514","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.rmed.2017.05.017","article-title":"Current approaches to the management of idiopathic pulmonary fibrosis","volume":"129","author":"Raghu","year":"2017","journal-title":"Respir Med"},{"key":"R56-20250514","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline","volume":"202","author":"Jacobs","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R57-20250514","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R58-20250514","doi-asserted-by":"crossref","first-page":"1801278","DOI":"10.1183\/13993003.01278-2018","article-title":"Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study","volume":"52","author":"Bajwah","year":"2018","journal-title":"Eur Respir J"},{"key":"R59-20250514","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(24)00187-5","article-title":"Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial","volume":"12","author":"Higginson","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R60-20250514","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/0269216315607180","article-title":"The importance of the feasibility study: lessons from a study of the hand-held fan used to relieve dyspnea in people who are breathless at rest","volume":"30","author":"Booth","year":"2016","journal-title":"Palliat Med"},{"key":"R61-20250514","doi-asserted-by":"crossref","first-page":"e13807","DOI":"10.1111\/psyp.13807","article-title":"The impact of unpredictability of dyspnea offset on dyspnea perception, fear, and respiratory neural gating","volume":"58","author":"von Leupoldt","year":"2021","journal-title":"Psychophysiology"},{"key":"R62-20250514","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/psyp.12881","article-title":"When dyspnea gets worse: suffocation fear and the dynamics of defensive respiratory responses to increasing interoceptive threat","volume":"54","author":"Benke","year":"2017","journal-title":"Psychophysiology"},{"key":"R63-20250514","doi-asserted-by":"crossref","first-page":"2301857","DOI":"10.1183\/13993003.01857-2023","article-title":"Cognitive behavioural therapy sessions approach ineffective for anxiety and depression in COPD: is the door closed for good?","volume":"63","author":"Yohannes","year":"2024","journal-title":"Eur Respir J"},{"key":"R64-20250514","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000370126","article-title":"Principles of rehabilitation and reactivation: interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement","volume":"89","author":"Holland","year":"2015","journal-title":"Respiration"},{"key":"R65-20250514","first-page":"CD013040","article-title":"Telerehabilitation for chronic respiratory disease","volume":"1","author":"Cox","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R66-20250514","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jpainsymman.2017.10.016","article-title":"Beyond idiopathic pulmonary fibrosis diagnosis: multidisciplinary care with an early integrated palliative approach is associated with a decrease in acute care utilization and hospital deaths","volume":"55","author":"Kalluri","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"R67-20250514","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1513\/AnnalsATS.201909-707OC","article-title":"Health care costs at the end of life for patients with idiopathic pulmonary fibrosis. evaluation of a pilot multidisciplinary collaborative interstitial lung disease clinic","volume":"17","author":"Kalluri","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"R68-20250514","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.21037\/apm-24-7","article-title":"Chronic breathlessness in fibrotic interstitial lung diseases-patient centered assessment and management in outpatient settings","volume":"13","author":"Kalluri","year":"2024","journal-title":"Ann Palliat Med"},{"key":"R69-20250514","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jpainsymman.2020.06.012","article-title":"Palliative care for idiopathic pulmonary fibrosis patients: pulmonary physicians\u2019 view","volume":"60","author":"Akiyama","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"R70-20250514","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/10499091211040232","article-title":"Palliative care for the interstitial lung disease patient a must and not just a need","volume":"39","author":"Chaaban","year":"2022","journal-title":"Am J Hosp Palliat Care"},{"key":"R71-20250514","first-page":"e50613","article-title":"Navigating compassion: a comprehensive review of palliative care in respiratory medicine","volume":"15","author":"Jadhav","year":"2023","journal-title":"Cureus"},{"key":"R72-20250514","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12904-021-00767-6","article-title":"Development and implementation of a transmural palliative care consultation service: a multiple case study in the Netherlands","volume":"20","author":"Engel","year":"2021","journal-title":"BMC Palliat Care"},{"key":"R73-20250514","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/02692163221135616","article-title":"Effectiveness of transmural team-based palliative care in prevention of hospitalizations in patients at the end of life: a systematic review and meta-analysis","volume":"37","author":"Flierman","year":"2023","journal-title":"Palliat Med"},{"key":"R74-20250514","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bmjspcare-2017-001330","article-title":"Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis","volume":"8","author":"Sharp","year":"2018","journal-title":"BMJ Support Palliat Care"},{"key":"R75-20250514","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.aucc.2018.11.065","article-title":"Nurses\u2019 perceived barriers and educational needs for early mobilisation of critical ill patients","volume":"32","author":"Kim","year":"2019","journal-title":"Aust Crit Care"},{"key":"R76-20250514","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0269216320981294","article-title":"Effectiveness and implementation of palliative care interventions for patients with chronic obstructive pulmonary disease: a systematic review","volume":"35","author":"Broese","year":"2021","journal-title":"Palliat Med"},{"key":"R77-20250514","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0269216315606645","article-title":"Education, implementation, and policy barriers to greater integration of palliative care: a literature review","volume":"30","author":"Aldridge","year":"2016","journal-title":"Palliat Med"},{"key":"R78-20250514","doi-asserted-by":"crossref","first-page":"2301076","DOI":"10.1183\/13993003.01076-2023","article-title":"Palliative care in COPD and ILD: a call for action","volume":"62","author":"Wijsenbeek","year":"2023","journal-title":"Eur Respir J"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:01:02Z","timestamp":1747245662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000753","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}